MOLN MOLECULAR PARTNERS AG
FollowADS (ADR), issuer CIK 1745114
Filings received so far for Q3 2026: 7 13F filers report a position in MOLN shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 2,221,494 | $8.69M | 0.24% | 0 | 13F-HRTimeline |
| BVF INC/ILin group BVF INC/IL | 1,353,968 | $5.19M | 0.17% | 0 | 13F-HRTimelineGroup |
| CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC | 12,372 | $47.4K | <0.01% | -4,807 | 13F-HRTimelineGroup |
| MORGAN STANLEYin group MORGAN STANLEY | 367 | $1.44K | <0.01% | 0 | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 151 | $590 | <0.01% | -128 | 13F-HRTimelineGroup |
| Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T… | 45 | $176 | <0.01% | new | 13F-HRTimelineGroup |
| JPMORGAN CHASE & COin group JPMORGAN CHASE & CO | 15 | $61 | <0.01% | new | 13F-HRTimelineGroup |